Editorial
Open access
Sep 2026
Are there true and false classifications in noninvasive liver disease assessment for metabolic dysfunction-associated steatotic liver disease?
HW, et al. Histological severity and hepatic outcomes in patients with metabolic dysfunction-associated steatotic liver disease and discrepant FIB-4 and liver stiffness measurement. Clin Mol Hepatol 2026;32:289-304
Tatsuki Ichikawa, Satoshi Miuma, Hisamitsu Miyaaki
· Hepatobiliary surgery and nu... · 0 citations